首页> 美国卫生研究院文献>The Oncologist >Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer

【2h】

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer

机译：卡铂联合Nab-紫杉醇I期和II期研究以及局部晚期非小细胞肺癌同时放疗的最新生存数据

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 The Oncologist
作者
Yuko Tsuchiya‐Kawano; Tomonari Sasaki; Hiroyuki Yamaguchi; Katsuya Hirano; Atsushi Horiike; Miyako Satouchi; Shinobu Hosokawa; Ryotaro Morinaga; Kazutoshi Komiya; Koji Inoue; Yuka Fujita; Ryo Toyozawa; Tomoki Kimura; Kosuke Takahashi; Kazuo Nishikawa; Junji Kishimoto; Yoichi Nakanishi; Isamu Okamoto;
展开▼
作者单位

展开▼
年(卷),期 2020(25),6
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 不能手术的Ⅲ期非小细胞肺癌患者每周紫杉醇和卡铂并同步放疗的诱导化疗：一个Ⅱ期研究结果 [J] . Hend Ahmed El-Hadaad, Hanan Ahmed Wahba, Eman Toson 中德临床肿瘤学杂志（英文版） . 2013,第002期
2. Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer [J] . Tsuchiya‐Kawano Yuko, Sasaki Tomonari, Yamaguchi Hiroyuki, The oncologist . 2020,第6期

机译：更新了Carboplatin Plus Nab-PACLitaxel和局部晚期非小细胞肺癌患者的同时放射治疗的I / II研究的存活数据
3. Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab-Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer [J] . Yuko Tsuchiya-Kawano, Koji Inoue, Yuka Fujita, The oncologist . 2020,第6期

机译：更新了Carboplatin Plus Nab-PACLitaxel和局部晚期非小细胞肺癌患者的同时放射治疗的I / II研究的存活数据
4. Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer [J] . Yuko Kawano, Tomonari Sasaki, Hiroyuki Yamaguchi, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2018,第期

机译：Carboplatin Plus Nab-PACLitaxel和局部晚期非小细胞肺癌患者的同时放射治疗的I / II研究
5. Gene expression profiles predict survival of patients with advanced non-small cell lung cancers [C] . Harun Roslan, Hadi Jalal, Mhazir Nur Shukriyah, 2011 Fourth International Conference on Modeling, Simulation and Applied Optimization . 2011

机译：基因表达谱预测晚期非小细胞肺癌患者的生存
6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
7. A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer [O] . Kan Wu, Lucheng Zhu, Jiahao Wang, 2019

机译：纳布-紫杉醇/卡铂联合胸腔放疗同时治疗局部晚期鳞状细胞癌的II期研究
8. A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer [O] . Tarhini, Ahmad A., Belani, Chandra P., Luketich, James D., 2011

机译：局部晚期III期非小细胞肺癌患者吞咽化学疗法（紫杉醇和卡铂）和胸腔放疗联合吞咽锰超氧化物歧化酶质粒脂质体保护的I期研究

Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅